Tefen Industrial Engineering, Management Consulting, and System Analysis Ltd is expanding its activities in Eastern Europe by opening an office in Bucharest after winning a number of projects in Romania.

Alan Erskine has been appointed Managing Director of Tefen UK.

(from the Globes writer) Tefen, a management consulting firm, has implemented the Due Diligence evaluation of the "Megofei Dorot" water plant for the Erisson Investments.

Life sciences partner Marc Puich is published in the latest issue of BioPharm International

Healthcare partner Tim Ward has been quoted in the November issue of Modern Healthcare

Tefen has acquired VC to expand its presence in Central Europe and its activities in the strategic consulting practice.

Tefen has been featured prominently in the November issue of Healthcare Informatics

Tefen forecasts Top 10 Healthcare Challenges in 2008

Tefen has been featured prominently in the November print issue of Health Executive.

Tefen’s director of healthcare Gil Amoray has been quoted as an industry expert in the November 2007 issue of Healthcare Purchasing News.

The acquisition will enable Tefen a rapid penetration into new geographic areas in Europe, add strategic consulting to the variety of consulting services the company provides, and increase its growth potential across Europe.

Tefen USA president Barry Calogero was featured as an industry analyst in trade publication Healthcare Finance News’ recent article, “Analysts say Clinton plan stops short by only addressing access to care.”

Tefen in collaboration with Bar Ilan University, is conducting an academic research with the objectives of localizing the SCOR model in various sectors.

July 26th, 2007. TEFEN LIMITED, the UK subsidiary of TEFEN LTD, fully owned by the company (100%) signed an agreement on acquiring the overwhelming majority of the equity of the Italian company Venture Consulting S.p.A (hereinafter referred to as VC).

After the success of the previous BioBenchmark in 2004, Tefen is again facilitating a benchmarking study at the request of existing clients and members of the BioPharma Operational Excellence Consortium.

Tefen's acquisitions in Israel and the results of the expansion efforts targeting the US pharmaceutical market, have led to a sharp growth of the company's operational revenues in the 4th quarter of 2006.

The acquisition will enable TEFEN a rapid penetration into the UK financial sector and increase the company's growth potential in Europe.

January 30, 2007 Tefen's UK, signed yesterday a Heads of Terms Agreement for acquiring the stock capital of a strategic consulting company operating mostly in Italy and Germany.